Evaluation of effectiveness and safety of a herbal compound in primary insomnia symptoms and sleep disturbances not related to medical or psychiatric causes
Giancarlo Palmieri,1,2 Paola Contaldi,1 Giuseppe Fogliame1 1ANARDI Medical and Scientific Association, Scafati, Italy; 2Department of Internal Medicine, Niguarda Cà Granda Hospital, Milan, Italy Background and purpose: Sleep disturbances and related daytime activities impairment are comm...
Saved in:
Main Authors: | Palmieri G, Contaldi P, Fogliame G |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/a82d2b067ea84009bfbc25ef210c4e46 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment
by: Meaklim H, et al.
Published: (2018) -
Sleep Disturbances in Patients with Nonepileptic Seizures
by: Vanek J, et al.
Published: (2021) -
Sleep-Wake Survival Dynamics in People with Insomnia
by: Hermans LWA, et al.
Published: (2021) -
Hyperarousal and sleep reactivity in insomnia: current insights
by: Kalmbach DA, et al.
Published: (2018) -
Feasibility of Patient-Controlled Sleep with Dexmedetomidine in Treating Chronic Intractable Insomnia
by: An JX, et al.
Published: (2020)